
Children's rehabilitation medical institution pilot project period extended by 3 years... 3rd project expanded to up to 56 locations
The government will promote a pilot project to support treatment of drug addicted patients starting in January of next year, and will extend the pilot project period for children's rehabilitation medical institutions, which ends this year, by three years and operate until the end of 2029.
AI-generated summary
The Ministry of Health and Welfare held the 19th Public Health Review and discussed the results of the pilot project to support treatment of drug addicted patients and the second pilot project to designate and operate children's rehabilitation medical institutions.
(Seoul = Yonhap News) Reporter Seongho Seong = The government will promote a pilot project to support treatment of drug addicted patients starting in January of next year.
The children's rehabilitation medical institution, which has been conducting a pilot project, decided to extend the project period by three years.
The Ministry of Health and Welfare held the 19th Health Insurance Policy Deliberation Committee (Health Care Review) on the 28th and discussed the performance evaluation agenda of the pilot project to support treatment of drug addicted patients and the second pilot project for designation and operation of children's rehabilitation medical institutions.
The Ministry of Health and Welfare plans to first prepare a compensation plan for drug addiction (price set by health insurance) to help treat drug addiction patients.
If drug addiction receives appropriate treatment at an early stage, recurrence can be prevented and social costs such as crime and medical expenses can be reduced.
However, drug addiction is often accompanied by complex diseases, making treatment difficult, and patient management requires a lot of resources such as manpower and time, so it has been pointed out that separate compensation is needed for professional treatment by medical institutions.
Accordingly, through a pilot project, the Ministry of Health and Welfare plans to prepare a compensation plan so that drug addicted patients can continue to receive management through rehabilitation institutions such as the Addiction Management Integrated Support Center even after returning to the community after receiving intensive and recovery treatment according to the level of addiction and treatment stage.
The Ministry of Health and Welfare will designate those that applied among the 11 regional treatment and protection institutions as pilot institutions and promote the project for three years.
In the case of the children's rehabilitation medical institution pilot project, whose second phase ends this year, the project period will be extended by three years and continue until the end of 2029.
The Children's Rehabilitation Medical Institution Pilot Project is a project that designates hospitals and clinics equipped with professional personnel and facilities so that children with disabilities under the age of 18 can receive rehabilitation treatment in a timely manner in their residential area, and applies intensive rehabilitation treatment fees depending on the patient's illness, age, etc.
A total of 39 locations (19 in the metropolitan area and 20 in the non-metropolitan area) participated in the second pilot project, and as of last year, approximately 3.46 million professional rehabilitation treatments were provided to 9,260 patients.
Compared to 2024, the beginning of the second phase of the project, the number of rehabilitation medicine specialists per institution increased from 3.0 to 3.2, and the number of physical and occupational therapists increased from 65.4 to 77.4.
However, there are differences in the use of specialized rehabilitation by region, such as no organizations participating in the project in some regions, and the need to improve the fee for intensive rehabilitation treatment for children has also been raised.
Accordingly, the Ministry of Health and Welfare plans to increase the number of institutions participating in the 3rd pilot project to a maximum of 56 (up to 68 including public children's rehabilitation medical hospitals and centers) and improve fees according to the age of patients.
AI outlook — possibilities, not facts
Pilot project to support treatment of drug addicted patients to be implemented in January next year
Very likely · Within months

Hospital prescriptions for ‘EPE’, Korea’s first GLP-1 type obesity treatment developed by Hanmi Pharmaceutical, began on the 29th. The supply price for the first four weeks is set at approximately 130,000 won, and attention is focused on whether it will settle in the domestic market based on price competitiveness and clinical results for Koreans.

SK Bioscience announced it will join a Bundibugyo virus vaccine development project backed by up to $99 million from BARDA, partnering with IAVI and Hilleman Laboratories to develop a single-dose vaccine.

The government will first execute 2.7 trillion won of the 3.6 trillion won in health insurance budget from January next year to strengthen regional and essential medical infrastructure. The Ministry of Health and Welfare held a public health hearing on the 28th and decided on implementation plans such as preferential regional rates, strengthening compensation for final treatment, and reforming the maternal and child medical system.

Save the Children announced on the 28th that it has supported approximately 200,000 people in response to Ebola in the Democratic Republic of Congo and is pursuing the establishment of an observation and care center for children exposed to Ebola.

Hyundai Pharmaceuticals announced to the National Assembly that it will submit supplementary data on its risk management plan for domestic approval of the abortion drug 'Mipgene' within next month. The medical community raised safety concerns, and the government responded that it was preparing to establish a safe use system.

A research team at Kangwon National University Hospital announced on the 27th that as a result of analyzing 4,274 pairs of mothers and newborns, ozone exposure in early pregnancy was found to be the most important factor predicting the risk of poor fetal growth, including low birth weight.